N-049

N/A

Report date: 2025/07/09 11:08:15
NME

Base Information

Drug NameN-049
Drug Alias NameN-049
ClassificationOther
Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 9
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesConvalife (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesConvalife (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A